acquired
Stage
About
Allcyte is a biotech spin-off from CeMM that performs functional drug testing on fresh primary human cancer tissue using a high-content imaging platform called Pharmacoscopy to support drug discovery and precision medicine research. The company was acquired by Exscientia in 2021.
Explore Allcyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.